Meta-backed research finds exposure to ‘untrustworthy’ social media is rare. The fine print is less reassuring 
Meta Stock Drops After Earnings Miss as AI Spending and Legal Costs Weigh on Profit 
Tesla Weighs China Business Separation Amid SpaceX Merger Speculation 
World game at war: why some European nations have threatened a World Cup boycott 
Roblox Stock Drops 16% as Q3 Bookings Forecast Misses Expectations 
Robinhood Q2 Earnings Beat Estimates, But HOOD Stock Falls as Investors Question Profit Quality 
Same sparkle, different story: how lab-grown diamonds are transforming the market 
Sony Raises Full-Year Outlook After Q1 Profit Jumps 40% on Gaming and Chip Growth 
SpaceX Wins $1.6 Billion U.S. Space Force Launch Contracts for Falcon 9 Missions Through 2027 
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat 
Apple Q3 Earnings Beat as Record iPhone Sales Offset Services, China Weakness 
WestJet Cancels 86 Flights as CUPE Strike Threat Disrupts Travel 
Arm Holdings Q1 Earnings Beat Estimates, Strong Q2 Outlook Fails to Lift ARM Stock 
Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says 
Toyota First-Half Global Sales and Production Decline on Weak China Demand, RAV4 Transition 
Samsung Q2 Profit Surges on AI Memory Chip Demand, Forecasts Strong Second Half 
OpenAI Revenue Surges After GPT-5.6 Launch as IPO Expectations Grow 
TORONTO, April 23, 2018 -- Axiom Real-Time Metrics, premier provider of unified eClinical solutions and services, is exhibiting at Clinical Operations in Oncology Trials West on April 24th and 25th in Burlingame, California.
The 2018 event is the 5th annual edition of the conference and brings together leading pharma and biotech professionals working in the oncology space from across the West Coast region.
“Fusion eClinical Suite provides uniquely tailored reports to support clinical oncology studies, including tumour response assessment and tracking, patient profiles, and biomarker reports. Axiom’s client roster includes many sponsors working on global oncology and plasma cell disorders including studies for the treatment of Multiple Myeloma, AML, CML, Hodgkin Lymphoma and Leukemia, among others. The easy-to-use, modular suite of tools is extremely flexible, enabling sponsors to manage all study data from Phase I to complex Phase III trials without having to change platforms or source additional vendors. It works exceptionally well for all studies, supporting US to global studies and enabling them to operate with far greater efficiency - speeding time to market,” shared Dr. Robert Arbeit, Chief Clinical Scientist.
Andrew Schachter, Founder and CEO concluded, “Our established ROI and delivery positions us as both cost efficient and best-in-class. We invite attendees to come and visit us at Booth 4 for a conversation and tailored demo over coffee.”
About Axiom Real-Time Metrics
Headquartered in Toronto, Canada, Axiom delivers intuitive, powerful and cost-effective eClinical solutions and services focused around your entire study. Services include: DM, Biostatistics and Pharmacovigilance. Axiom's eClinical suite, Fusion, delivers a powerful range of innovative end-user focused, unified functionality and 15 modules. Axiom serves as the Connected Hub for your entire clinical study data and operational needs. Fusion Delivers: EDC, DM, IWRS, CTMS, Inventory Management, IVR, Patient Portal, AE/SAE Tracking, Safety Database, Central Lab, Imaging, eTMF, and 24/7 Project and Clinical Data Reporting. For more information, please visit http://www.axiommetrics.com/.
Contact
[email protected]
+1.877.321.9191
PR Contact
Sarah Glofcheskie
[email protected]
+1.647.588.9073
